Product Information
CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2170 per ML under NDC 68180040202. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040202
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065261FDA Approved
12/19/2005
TE Code
AB
On Market Since
12/1/2005
Price Statistics
The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 61.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2170 per ML |
|---|---|
| All-time high | $0.5641 (Jun 11, 2014) |
| All-time low | $0.1433 (Aug 21, 2024) |
| 52-week high | $0.2170 |
| 52-week low | $0.1655 |
| Median price | $0.2702 |
| Average price | $0.3278 |
| Largest weekly change | +58.3% (Feb 23, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.2170 per ML (NDC 68180040202), effective Aug 19, 2026.
How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 61.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1433 (Aug 21, 2024) to a high of $0.5641 (Jun 11, 2014), with a median of $0.2702 per ML.
Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 250 MG/5 ML SUSP, is $0.1470 per ML — about 32% below CEFPROZIL 250 MG/5 ML SUSP.
Who manufactures CEFPROZIL 250 MG/5 ML SUSP?
CEFPROZIL 250 MG/5 ML SUSP (NDC 68180040202) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.